Background: This study aimed to evaluate the etiology, clinic and laboratory features of acute pancreatitis (AP) in children retrospectively. We also aimed to determine the effects of clinical, laboratory and radiological markers on length of hospital stay (LOS). Materials and methods: This study was conducted of 133 patients diagnosed with AP. Patients were divided into two groups based on LOS: ≤7 days and >7 days. Demographic, clinical, laboratory and radiological parameters, as well as time to initiation of feeding, were analyzed. Results: The mean age of patients was 11.2 ± 4.8 years, and 54.1% were male. The most common etiologies were obstructive (30.8%) and idiopathic (29.3%). Drug-induced and traumatic causes were significantly more prevalent in patients with a hospital stay of more than seven days (p = 0.001). Radiological findings other than pancreatic edema (peripancreatic fluid, pleural effusion, or ascites) were significantly associated with prolonged LOS (p = 0.002). A positive correlation was observed between LDH and LOS (r = 0.253, p = 0.031). LOS was significantly shorter in patients who initiated oral feeding within 48 h (p < 0.001). Conclusions: LOS in pediatric AP is influenced by laboratory parameters, radiological findings, and the timing of feeding initiation. Identifying early prognostic indicators, particularly in the pediatric patient group, may guide individualized management and improve clinical outcomes.
Introduction: The neutrophil-to-lymphocyte ratio (NLR) is an established prognostic marker in adult malignancies, including Hodgkin lymphoma (HL). However, its clinical significance in pediatric HL remains uncertain due to biological differences and generally favorable outcomes. This study aimed to evaluate the prognostic value of the diagnostic NLR in predicting relapse, refractory disease, and mortality in children with HL. Materials and methods: Eighty-two patients under 18 years of age who were diagnosed with HL between 2005 and 2025 were retrospectively analyzed. Clinical features, laboratory parameters, treatment response, and survival outcomes were assessed. The NLR was calculated from baseline blood counts obtained before therapy. Receiver operating characteristic (ROC) curve analysis, Kaplan–Meier survival estimates, and logistic regression models were used to determine the prognostic performance of the NLR alongside conventional factors such as stage, B symptoms, albumin, and the erythrocyte sedimentation rate. Results: The mean NLR at diagnosis was 3.76 ± 2.77. ROC analysis revealed poor discriminative power (AUC = 0.517, p = 0.822). Event-free survival (EFS) and overall survival (OS) did not differ between the high and low NLR groups ( p = 0.870 and p = 0.315, respectively). In the multivariable logistic regression, early two-cycle chemotherapy response remained an independent predictor of adverse outcomes ( p = 0.002), whereas bulky disease showed borderline significance ( p = 0.059). The NLR and other inflammatory markers, including the ESR and albumin, were not associated with poor prognosis. Conclusion: The diagnostic NLR lacks independent prognostic value in this pediatric HL cohort. These findings highlight the biological distinctness of pediatric disease and suggest that adult-derived inflammatory biomarkers should not be directly extrapolated to childhood malignancies.